Physician profile

Thomas Fabian

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New Haven, CT

NPI 1235101320

$11,185.66

in general payments reported to CMS, 2019-2025

15 companies · $3,484 in 2025

The $3,484 reported for 2025 was more than what 77% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$3,222.00
Food and Beverage$1,168.64

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $9,938.67 2019-2025 Imfinzi, Breztri, Tezspire
Medtronic, INC. $475.66 2022-2025 Signia, Endo Gia Ultra, Endurant Iis
Atricure, INC. $156.52 2023-2025 Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System, Atriclip Laa Exclusion System
Intuitive Surgical, INC. $110.99 2019-2022
Regeneron Healthcare Solutions, INC. $110.45 2023 Libtayo
E.R. Squibb & Sons, L.L.C. $100.66 2025 Opdivo
Zimmer Biomet Holdings, INC. $63.37 2023
Ethicon US, LLC $57.95 2021-2022
Depuy Synthes Sales INC. $35.61 2020
Ethicon INC. $34.73 2021
Surgical Specialties Corporation (US), INC. (Dba Corza Medical) $31.87 2024-2025
Elutia, INC. $20.16 2020
Celgene Corporation $16.76 2025 Opdivo
Veran Medical Technologies, INC. $16.70 2019
Baxter Healthcare $15.56 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas Fabian

$11,185.66

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $3,484 reported for 2025 was more than what 77% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/853503/thomas-fabian

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.